View Older Stories View More Recent Stories
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
Faruqi & Faruqi Reminds Cassava Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 - SAVA
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
Cassava Sciences (SAVA) call put ratio 1.7 calls to 1 put on option volume of 155K contracts as share price down 84%
-
Jones Trading Reiterates Hold Rating on Cassava Sciences (SAVA)
-
Rodman & Renshaw Downgrades Cassava Sciences (SAVA) to Sell, PT $20 (from $107)
-
Cassava Sciences (SAVA) to Resume Trading at 8 a.m.
-
Cassava Sciences (SAVA) Topline Phase 3 Data Did Not Meet Co-Primary Endpoints
-
Cassava Sciences (SAVA) Halted, News Pending
-
Cassava Sciences (SAVA) Appoints Freda Nassif as Chief Commercial Officer
-
Cassava Sciences (SAVA) Reports Q3 Results and Update
-
Cassava Sciences, Inc. (SAVA) Tops Q3 EPS by 15c
-
Cassava Sciences (SAVA) CEO Rick Barry Issues Open Letter
-
Cassava Sciences (SAVA) shares edge lower, STAT urges FDA to intervene to protect patients
-
Cassava Sciences (SAVA) options active as share price down 10.5%
-
Cassava Sciences (SAVA) Resolves SEC Investigation
-
Cassava Sciences (SAVA) Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
-
Cassava Sciences (SAVA) Appoints Rick Barry as CEO
-
Cassava Sciences, Inc. (SAVA) Tops Q2 EPS by 54c
-
Cassava Sciences (SAVA) Announces Passing of Director Sandy Robertson
-
Cassava Sciences (SAVA) Announces Expansion of Open-Label Extension Trials
-
Cassava Sciences (SAVA) Executive Chairman Issues Open Letter
-
H.C. Wainwright Reiterates Cassava Sciences (SAVA) at Neutral following management changes
-
Cassava Sciences (SAVA): Remi Barbier resigns as President and CEO and from the Board of Directors
-
Midday movers: Spirit Aerosystems, Tesla rise; Chewy falls
-
Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'
-
Cassava Sciences (SAVA) Provides Update on Government Investigations
